The potential for vitamin D receptor activation in cardiovascular research

Bibliography

• DELUCA HF: The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D3, a calcium-mobilizing hormone. N. Engl. J. Med. (1973) 289:359-365.
   PubMed Web of Science ®Google Scholar
• JONES G, STRUGNELL SA, DELUCA HF: Current understanding of the molecular actions of vitamin D. Physiol. Rev. (1998) 78:1193-1231.
   PubMed Web of Science ®Google Scholar
• ANDRESS DL: Vitamin D treatment in chronic kidney disease. Semin. Dial. (2005) 18:315-321.
   PubMed Web of Science ®Google Scholar
• WEINER DE, TIGHIOUART H, AMIN MG et al.: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol. (2004) 15:1307-1315.
   PubMed Web of Science ®Google Scholar
• CORESH J, BYRD-HOLT D, ASTOR BC et al.: Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J. Am. Soc. Nephrol. (2005) 16:180-188.
   PubMed Web of Science ®Google Scholar
• BAIGENT C, BURBURY K, WHEELER D: Premature cardiovascular disease in chronic renal failure. Lancet (2000) 356:147-152.
   PubMed Web of Science ®Google Scholar
• LIND L, HANNI A, LITHELL H, HVARFNER A, SORENSEN OH, LJUNGHALL S: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am. J. Hypertens. (1995) 8:894-901.
   PubMed Web of Science ®Google Scholar
• SHAN J, RESNICK LM, LEWANCZUK RZ, KARPINSKI E, LI B, PANG PK: 1,25-dihydroxyvitamin D as a cardiovascular hormone. Effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am. J. Hypertens. (1993) 6:983-988.
   PubMed Web of Science ®Google Scholar
• TIMMS PM, MANNAN N, HITMAN GA et al.: Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM (2002) 95:787-796.
   PubMed Web of Science ®Google Scholar
• WU-WONG JR, NAKANE M, MA J, RUAN X, KROEGER PE: Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis (2006) 186:20-28.
   PubMed Web of Science ®Google Scholar
• WU J, GARAMI M, CHENG T, GARDNER DG: 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J. Clin. Invest. (1996) 97:1577-1588.
   PubMed Web of Science ®Google Scholar
• ROSTAND SG: Seasonal changes in blood pressure in patients undergoing hemodialysis. N. Engl. J. Med. (1999) 340:965-966.
   PubMedGoogle Scholar
• ROSTAND SG, DRUEKE TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. (1999) 56:383-392.
   PubMed Web of Science ®Google Scholar
• LI YC, PIRRO AE, AMLING M et al.: Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA (1997) 94:9831-9835.
   PubMed Web of Science ®Google Scholar
• KONG J, LI YC: Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2003) 285(1):R255-R261.
   PubMed Web of Science ®Google Scholar
• LI YC: Vitamin D regulation of the renin–angiotensin system. J. Cell. Biochem. (2003) 88:327-331.
   PubMed Web of Science ®Google Scholar
• AIHARA K, AZUMA H, AKAIKE M et al.: Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J. Biol. Chem. (2004) 279:35798-35802.
   PubMed Web of Science ®Google Scholar
• VILES-GONZALEZ JF, FUSTER V, BADIMON JJ: Links between inflammation and thrombogenicity in atherosclerosis. Curr. Mol. Med. (2006) 6:489-499.
   PubMed Web of Science ®Google Scholar
• WU-WONG JR, NAKANE M, MA J: Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells. Thromb. Res. (2006) 118(6):709-714.
   PubMed Web of Science ®Google Scholar
• KOYAMA T, SHIBAKURA M, OHSAWA M, KAMIYAMA R, HIROSAWA S: Anticoagulant effects of 1α,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Blood (1998) 92:160-167.
   PubMed Web of Science ®Google Scholar
• OHSAWA M, KOYAMA T, YAMAMOTO K, HIROSAWA S, KAMEI S, KAMIYAMA R: 1α,25-dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation (2000) 102:2867-2872.
   PubMed Web of Science ®Google Scholar
• KALANTAR-ZADEH K, KUWAE N, REGIDOR DL et al.: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. (2006) 70:771-780.
   PubMed Web of Science ®Google Scholar
• YOUNG EW, ALBERT JM, AKIBA T et al.: Vitamin D therapy and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol. (2005) 16:TH-PO0735.
   Google Scholar
• TENG M, WOLF M, OFSTHUN MN et al.: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J. Am. Soc. Nephrol. (2005) 16:1115-1125.
   PubMed Web of Science ®Google Scholar
• TENG M, WOLF M, LOWRIE E, OFSTHUN N, LAZARUS JM, THADHANI R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N. Engl. J. Med. (2003) 349:446-456.
   PubMed Web of Science ®Google Scholar
• SHOJI T, SHINOHARA K, KIMOTO E et al.: Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population. Nephrol. Dial. Transplant. (2004) 19:179-184.
   PubMed Web of Science ®Google Scholar
• PARK CW, OH YS, SHIN YS et al.: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am. J. Kidney Dis. (1999) 33:73-81.
   PubMed Web of Science ®Google Scholar
• BOLEGO C, VEGETO E, PINNA C, MAGGI A, CIGNARELLA A: Selective agonists of estrogen receptor isoforms. New perspectives for cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. (2006) 26(10):2192-2199.
   PubMed Web of Science ®Google Scholar